In this HCC model multi-kinase-inhibitor sorafenib treatment-induced hypoxia fostered SDF-1 production, leading to the recruitment of immunosuppressive tumor-associated macrophages, myeloid-derived suppressive cells, and Tregs all with increased PD-L1 expression. The gene discussed is CXCL12; the disease is hepatocellular carcinoma.